APA (7th ed.) Citation

Hwang, D. Y., Eom, J., Jang, J. E., Jeung, H., Chung, H., Kim, J. S., . . . Min, Y. H. (2020). ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia. Journal of Experimental & Clinical Cancer Research (17569966), 39(1), 1. https://doi.org/10.1186/s13046-020-01580-4

Chicago Style (17th ed.) Citation

Hwang, Doh Yu, Ju-In Eom, Ji Eun Jang, Hoi-Kyung Jeung, Haerim Chung, Jin Seok Kim, June-Won Cheong, and Yoo Hong Min. "ULK1 Inhibition as a Targeted Therapeutic Strategy for FLT3-ITD-mutated Acute Myeloid Leukemia." Journal of Experimental & Clinical Cancer Research (17569966) 39, no. 1 (2020): 1. https://doi.org/10.1186/s13046-020-01580-4.

MLA (9th ed.) Citation

Hwang, Doh Yu, et al. "ULK1 Inhibition as a Targeted Therapeutic Strategy for FLT3-ITD-mutated Acute Myeloid Leukemia." Journal of Experimental & Clinical Cancer Research (17569966), vol. 39, no. 1, 2020, p. 1, https://doi.org/10.1186/s13046-020-01580-4.